NCT07661238

Brief Summary

This prospective randomized controlled trial compares the effects of Minimally Invasive Extracorporeal Circulation (MiECC) versus conventional cardiopulmonary bypass (CPB) on optic nerve sheath diameter (ONSD) and postoperative stroke incidence in adult patients undergoing isolated open heart surgery. ONSD will be measured by ultrasound at 7 predefined time points (T0-T6). Primary outcomes include perioperative ONSD changes and 30-day stroke incidence. Secondary outcomes include TIA, delirium (CAM-ICU), MoCA scores, ICU and hospital stay, AKI, and transfusion requirements.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
1mo left

Started Nov 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Nov 2025Sep 2026

Study Start

First participant enrolled

November 1, 2025

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

May 7, 2026

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 22, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2026

Last Updated

June 22, 2026

Status Verified

June 1, 2026

Enrollment Period

10 months

First QC Date

May 7, 2026

Last Update Submit

June 18, 2026

Conditions

Keywords

Optic Nerve Sheath DiameterMinimally Invasive Extracorporeal CirculationNeurological ComplicationsCardiac Surgery

Outcome Measures

Primary Outcomes (2)

  • ONSD change from baseline (T0 to T6)

    Bilateral ONSD measured by ultrasound (7.5-10 MHz linear probe) at 3 mm posterior to the optic disc. Three measurements per eye, mean value recorded. Change assessed from preoperative baseline (T0) through postoperative hour 24 (T6).

    Measured by ultrasound at 7 time points intraoperative time period

  • 30-day stroke incidence

    Stroke defined as focal or global neurological deficit lasting more than 24 hours, confirmed by neuroimaging (CT or MRI), and graded by NIHSS score.

    postoperative 30 days

Study Arms (2)

MiECC Group

Patients undergoing isolated open heart surgery using minimally invasive extracorporeal circulation (closed-circuit, no venous reservoir, heparin-coated tubing, minimal prime volume \~500-700 mL)

Conventional CPB Group

Patients undergoing isolated open heart surgery using conventional cardiopulmonary bypass (open cardiotomy reservoir, gravity drainage, prime volume \~1500-2000 mL)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

,elective 18-80 aged, coronary bypass surgery patients with pump convansionel and MIECC

You may qualify if:

  • Age 18 to 80 years
  • Scheduled for elective isolated open heart surgery
  • Requires cardiopulmonary bypass
  • Able to provide written informed consent
  • Adequate ultrasonographic window for ONSD measurement

You may not qualify if:

  • Emergency or salvage surgery
  • Off-pump, revision, or combined cardiac surgery
  • History of stroke or TIA within the last 6 months
  • Pre-existing neurological deficit
  • Bilateral optic nerve pathology
  • History of ocular trauma or surgery
  • Intracranial mass or hydrocephalus
  • Requirement for deep hypothermic circulatory arrest
  • Alcohol or substance dependency
  • Left ventricular ejection fraction \<30%
  • Renal or hepatic failure with risk of advanced encephalopathy
  • Preoperative requirement for mechanical circulatory support
  • Symptomatic or severe carotid artery stenosis (\>70%)
  • Refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Health Sciences Bursa Yüksek Ihtisas Training and Research Hospital

Bursa, Yıldırım, 16600, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Tuğba T ONUR, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    PRINCIPAL INVESTIGATOR
  • Aygül A GÜNEŞ, MD

    Bursa Yuksek Ihtisas Training and Research Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
MD, Anesthesiology and Reanimation

Study Record Dates

First Submitted

May 7, 2026

First Posted

June 22, 2026

Study Start

November 1, 2025

Primary Completion (Estimated)

September 1, 2026

Study Completion (Estimated)

September 1, 2026

Last Updated

June 22, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Locations